Professor, Pathology and Microbiology, University of Nebraska Medical Center College of Medicine
Pathology
Dr. Timothy C. Greiner, MD
|
|
Give Review
Dr. Timothy C. Greiner is an expert in the field of Pathology. He studied medicine at University of Iowa Carver College of Medicine. University of Iowa Carver College of Medicine has a rank of 29 in research and a 16 in primary care Timothy C. Greiner is also published. He has 64 publications published. The lastest publication: "Background differences in baseline and stimulated MMP levels influence abdominal aortic aneurysm susceptibility.' He accepts all Medicare patients.
Publications
- Background differences in baseline and stimulated MMP levels influence abdominal aortic aneurysm susceptibility.
- IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.
- Leukemic diffuse large B-cell lymphoma in a patient with myeloproliferative disorder.
- Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggresive B-cell lymphoma.
- Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care.
- Gene expression signatures delineate biologic and prognostic subgroups in peripheral T-cell lymphoma.
- Autoimmune neutropenia in multiple myeloma and the role of clonal T-cell expansion: evidence of cross-talk between B-cell and T-cell lineages?
- Laboratory practice guidelines for detecting and reporting JAK2 and MPL mutations in myeloproliferative neoplasms: a report of the Association for Molecular Pathology.
- Genome-wide copy number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.
- B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases.
- Comparison Study of the Performance of the QIAGEN EGFR RGQ and EGFR pyro assays for mutation analysis in non-small cell lung cancer.
- microRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma.
- CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma.
- Cytogenetic abnormalities in follicular dendritic cell sarcoma: report of two cases and literature review.
- Investigation of the BRAF V600E Mutation by Pyrosequencing in Lymphoproliferative Disorders.
- Immunohistochemical and molecular cytogenetic evaluation of potential targets for tyrosine kinase inhibitors in Langerhans cell histiocytosis.
- A new biological prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma.
- Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling.
- Genome-wide MicroRNA profiling of mantle cell lymphoma reveal a distinct subgroup with poor prognosis.
- Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA stra...
- Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis.
- Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation.
- BCL2 Predicts Survival in Germinal Center B-cell-like Diffuse Large B-Cell Lymphoma Treated with CHOP-like therapy and Rituximab.
- Integrated profiling of diffuse large B-cell lymphoma with 7q gain.
- Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP.
- Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.
- Assay design affects the interpretation of T-cell receptor gamma gene rearrangements: comparison of the performance of a one-tube assay with the BIOMED-2-based TCRG ge...
- Identification and functional relevance of de novo DNA methylation in cancerous B-cell populations.
- t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region.
- A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.
- Membrane-type 1 matrix metalloproteinase regulates macrophage-dependent elastolytic activity and aneurysm formation in vivo.
- Stromal gene signatures in large-B-cell lymphomas.
- Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.
- The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overal...
- Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse la...
- Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma.
- Implementation of a T4 extraction control for molecular assays of cerebrospinal fluid and stool specimens.
- Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymph...
- Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
- Enhanced detection of TP53 mutations using a GC-clamp in denaturing high performance liquid chromatography.
- Mantle cell lymphoma with plasma cell differentiation.
- Diagnostic assays for the JAK2 V617F mutation in chronic myeloproliferative disorders.
- BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
- Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
- Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma.
- Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
- Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.
- BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
- Key roles of CD4+ T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model.
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
- Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.
- Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells.
- The distribution of gene segments in T-cell receptor gamma gene rearrangements demonstrates the need for multiple primer sets.
- Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma.
- A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival.
- Removal of mercuric chloride deposits from B5-fixed tissue will affect the performance of immunoperoxidase staining of selected antibodies.
- The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma.
- Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus.
- The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade.
- Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms.
- Effectiveness of capillary electrophoresis using fluorescent-labeled primers in detecting T-cell receptor gamma gene rearrangements.
- The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile.
- Cytogenetic characterization of diffuse large cell lymphoma using multi-color fluorescence in situ hybridization.
Schools
University of Ia Roy J amp L Carver Com
University Ia
Nci
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
University of Iowa Hospitals and Clinics -
University of Iowa Carver College of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1447208210 |
| Last Name Of The Provider | GREINER |
| First Name Of The Provider | TIMOTHY |
| View All |
Similar Doctors
|
|
Dr. Charles H. Mosher, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle P. Elieff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rodney D. McComb, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Shane K. Kohl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan G. Torell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stacey T. McManigal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel Olson, MD |
|
|
Dr. Elza G. Matrova, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Whitney R. Wedel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Panganiban, MD |
|
|
Dr. Jian Shen, MD |